INS and Alzheimer disease: Insulin resistance leads to changes in insulin signaling through the PBK/AKT and MAPK pathways, leading to metabolic effects and cell homeostasis [47]; changes in insulin resistance may contribute to the sustained chronic inflammatory response in the AD brain that facilitates neurofibrillary tangle development and β-amyloid plaques [48].